ANDRA WALKER: Open Payments
NPI 1508041211 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 40 payments from 14 companies in 2025. Trend: 2023 $187 · 2024 $848 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $162 |
| Lilly USA, LLC | 4 | $84 |
| Novo Nordisk Inc | 5 | $82 |
| Dexcom, Inc. | 4 | $68 |
| PFIZER INC. | 3 | $58 |
| Amgen Inc. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Boston Scientific Corporation | 1 | $31 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $28 |
Products named: MOUNJARO, Dexcom G6 Transmitter, Wegovy, VRAYLAR, QULIPTA, DALVANCE, AIRSUPRA, WATCHMAN FLX.
Industry payments across KS — which companies pay providers there.
